This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: LLL MKTO NBR UHS UMPQ


L-3 Communications
(LLL - Get Report) was upgraded at RBC Capital to sector perform. Twelve-month price target is $120. U.S. defense budget outlook is stabilizing, RBC Capital said.

Marketo (MKTO) was upgraded at UBS to neutral from sell. Valuation call with about 20% pullback on no fundamental news, UBS said. Twelve-month price target is $40.

Nabors (NBR) was upgraded at Credit Suisse to neutral from underperform. Twelve-month price target is $22. Estimates were also increased, given strong international execution, Credit Suisse said.

Union First (UBSH) was downgraded at Sterne Agee to neutral from buy. Estimates were also cut, given lower expected loan and mortgage growth, Sterne Agee said.

Universal Health (UHS - Get Report) was upgraded at Keybanc to buy from hold. Twelve-month price target is $86. Stock offers a compelling entry point following the recent pullback, Keybanc said.

Umpqua (UMPQ) was downgraded at RBC Capital to sector perform from outperform. Twelve-month price target is $20. Company has a weaker core earnings outlook, RBC Capital said.

Stock Comments / EPS Changes

Amgen (AMGN) estimates, price target were boosted at Citigroup. Twelve-month price target is now $155. Estimates were also increased, given the prospects of the company's cholesterol drug, PCSK9, Citigroup said. Buy rating. (AMZN) numbers were raised at Oppenheimer. Twelve-month price target is now $455. Estimates were also increased, given higher prime pricing and continued expected market share gains, Oppenheimer said. Outperform rating.

Actuant (ATU) price target, EPS estimates were lowered at Jefferies. Driven by lack of improvement in key end-markets in Europe, Jefferies said. Twelve-month price target is now $44. Buy rating.

Citigroup (C) price target, estimates were cut at Jefferies. Driven largely by lower trading estimates and higher expenses, Jefferies said. Twelve-month price target is $56. Hold rating.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
LLL $121.88 -1.20%
UHS $120.29 -2.00%
AAPL $132.65 1.82%
FB $81.91 0.47%
GOOG $555.39 -1.70%


DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs